A randomised trial of weekly cetuximab and radiation versus weekly cisplatin and radiation in good prognosis loco regionally advanced HPV-associated oropharyngeal squamous cell carcinoma
Primary Sponsor
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
189
Closing Date of Accrual
7th June 2018
Trial Chairperson
Prof Danny Rischin and A/Prof June Corry
Trial Contact
anetta.matera@petermac.org
Clinical Trial Registration
Related Post
18 October, 2022
NINJA Radiation Therapy Trial participant tells his journey to treatment
The journey to becoming the 200th participant for the
6 September, 2022
The gift that kept on giving
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
